Anthony Adamis
Director/Board Member at EYEPOINT PHARMACEUTICALS, INC.
Net worth: 782 677 $ as of 2024-04-29
Anthony Adamis active positions
| Companies | Position | Start | End |
|---|---|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Director/Board Member | 2022-06-22 | - |
| Independent Dir/Board Member | 2022-06-22 | - | |
(OSI) Eyetech
 (OSI) Eyetech Medical SpecialtiesHealth Technology OSI Eyetech provides medical services. It is specializee in the development and commercialization of therapeutics to treat diseases of the eye. The company is headquartered in New York City, NY. | Chief Tech/Sci/R&D Officer | - | - |
| Retinal Degeneration Fund | Director/Board Member | 2021-09-30 | - |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Director/Board Member | 2021-11-30 | - |
Eyebiotech Ltd.
 Eyebiotech Ltd. Pharmaceuticals: MajorHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Director/Board Member | 2021-07-31 | - |
| Founder | 2021-07-31 | - | |
Spiral Therapeutics, Inc.
 Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA. | Director/Board Member | 2021-09-30 | - |
| Independent Dir/Board Member | 2021-09-30 | - | |
| Theia Therapeutics, Inc. | Director/Board Member | 2021-10-31 | - |
Career history of Anthony Adamis
Former positions of Anthony Adamis
| Companies | Position | Start | End |
|---|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Director/Board Member | 2021-12-05 | 2022-02-16 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Training of Anthony Adamis
| University of Illinois | Undergraduate Degree |
| Pritzker School of Medicine | Doctorate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 4 |
| Australia | 2 |
Operational
| Director/Board Member | 7 |
| Chief Tech/Sci/R&D Officer | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
(OSI) Eyetech
(OSI) Eyetech Medical SpecialtiesHealth Technology OSI Eyetech provides medical services. It is specializee in the development and commercialization of therapeutics to treat diseases of the eye. The company is headquartered in New York City, NY. | Health Technology |
Spiral Therapeutics, Inc.
Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA. | Commercial Services |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
| Retinal Degeneration Fund | |
| Theia Therapeutics, Inc. | |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Eyebiotech Ltd.
Eyebiotech Ltd. Pharmaceuticals: MajorHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Health Technology |
- Stock Market
- Insiders
- Anthony Adamis
- Experience